Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease
- aRoyal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath BA1 1RL, UK, bBath Institute for Rheumatic Diseases, Trim Bridge, Bath BA1 1HD, UK, cDiabetes and Lipid Research Group, Wolfson Centre, Royal United Hospital, Bath, UK
- Dr S M Jones, Consultant Rheumatologist, University Hospital of Wales, Heath Park, Cardiff, Wales Email:sharon.jones{at}uhw-tr.wales.nhs.uk
- Accepted 10 April 2000
Abstract
OBJECTIVES (a) To characterise the lipid profile in psoriatic arthritis and investigate whether there are similarities to the dyslipoproteinaemia reported in rheumatoid arthritis and other inflammatory forms of joint disease; (b) to investigate whether there is an atherogenic lipid profile in psoriatic arthritis, which may have a bearing on mortality.
METHODS Fasting lipids, lipoproteins, and their subfractions were measured in 50 patients with psoriatic arthritis and their age and sex matched controls.
RESULTS High density lipoprotein cholesterol (HDL cholesterol) and its third subfraction, HDL3 cholesterol, were significantly reduced and the most dense subfraction of low density lipoprotein (LDL), LDL3, was significantly increased in the patients with psoriatic arthritis. Twenty patients with active synovitis had significantly lower total cholesterol, LDL cholesterol, and HDL3 cholesterol than their controls. 25% of the patients with psoriatic arthritis had raised Lp(a) lipoprotein levels (>300 mg/l) compared with 19% of controls, but this was not statistically significant.
CONCLUSION Raised levels of LDL3 and low levels of HDL cholesterol are associated with coronary artery disease. Such an atherogenic profile in a chronic inflammatory form of arthritis is reported, which may be associated with accelerated mortality.
